Galixir
Company

Last deal

Amount

Series A

Stage

29.12.2020

Date

2

all rounds

$10M

Total amount

General

About Company
Galixir is an AI technology for drug research and development.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Xingyao Technology

founded date

01.01.2019

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

The platform combines engineering chemistry, computational chemistry, computational biology, and cloud computing technologies to expedite drug discovery processes. Galixir offers services such as target identification, optimization, synthesis prediction, and experiment validation, which help drug research and development scientists save time and cost. The platform also provides comprehensive patent protection coverage for the drugs developed.